Barouyr Baroudjian
Overview
Explore the profile of Barouyr Baroudjian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
691
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vitek L, Goronflot T, Dutriaux C, Deleuze A, Le Corre Y, Duval-Modeste A, et al.
Acta Derm Venereol
. 2024 Dec;
104:adv41297.
PMID: 39670438
Metastatic uveal melanoma is a rare disease with a poor prognosis. Usual treatments have not proven effective. Tebentafusp, a bispecific protein targeting melanoma cells and T lymphocytes, is the first...
2.
Rousset P, Nardin C, Maubec E, Heidelberger V, Picard A, Troin L, et al.
Oncologist
. 2024 Jul;
29(10):e1364-e1372.
PMID: 38956747
Background: Currently, treatment options for patients with advanced melanoma who experience failed immunotherapy or targeted therapy are lacking. Recent studies suggest the antitumor activity of combined pembrolizumab and lenvatinib in...
3.
Dauendorffer J, Plantier F, Bouaziz J, Lebbe C, Baroudjian B
J Eur Acad Dermatol Venereol
. 2024 Jun;
39(2):e158-e159.
PMID: 38923023
No abstract available.
4.
Louveau B, Nakouri I, Jouenne F, Baroudjian B, Sadoux A, Meda L, et al.
Br J Dermatol
. 2024 Jun;
191(4):639-641.
PMID: 38836587
No abstract available.
5.
Idoudi S, Battistella M, El Zeinaty P, Tavernier C, Lebbe C, Baroudjian B
J Eur Acad Dermatol Venereol
. 2024 Mar;
38(10):e874-e876.
PMID: 38487987
No abstract available.
6.
Stefanski M, Guern A, Visseaux L, Ehret M, Colomb M, Jeudy G, et al.
J Am Acad Dermatol
. 2024 Feb;
91(1):51-56.
PMID: 38387851
Background: Studies demonstrating the potential utility of reflectance confocal microscopy (RCM) have been performed under experimental conditions. Objective: To provide an overview of RCM practice in real-life. Methods: A multicenter,...
7.
Grolleau C, Walter-Petrich A, Dupin N, Chanal J, Zehou O, Montlahuc C, et al.
Br J Dermatol
. 2024 Jan;
190(5):771-773.
PMID: 38270968
No abstract available.
8.
Louveau B, Reger De Moura C, Jouenne F, Sadoux A, Allayous C, Meda L, et al.
Melanoma Res
. 2023 Dec;
34(2):186-192.
PMID: 38141200
Upregulation of phosphodiesterase type 4 (PDE4) has been associated with worse prognosis in several cancers. In melanomas harboring NRAS mutations, PDE4 upregulation has been shown to trigger a switch in...
9.
Reichert C, Baldini C, Mezghani S, Maubec E, Longvert C, Mortier L, et al.
Cancers (Basel)
. 2023 Sep;
15(17).
PMID: 37686606
Data regarding elderly melanoma patients treated with anti-PD-1 or anti-CTLA-4 antibodies are in favor of tolerability outcomes that are similar to those of younger counterparts. However, there are very few...
10.
Lai-Kwon J, Jacques S, Carlino M, Benannoune N, Robert C, Allayous C, et al.
Eur J Cancer
. 2023 Apr;
186:12-21.
PMID: 37018924
Background: Differing doses of ipilimumab (IPI) are used in combination with an anti-PD1 antibody in advanced melanoma. There is no data on the outcomes of patients who progress following low-dose...